We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+12.51%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$1.86B
AUM Growth
+$246M
Cap. Flow
+$82.5M
Cap. Flow %
4.43%
Top 10 Hldgs %
34.22%
Holding
1,158
New
69
Increased
498
Reduced
498
Closed
91

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$12.9M
2
MSFT icon
Microsoft
MSFT
+$12.5M
3
NVDA icon
NVIDIA
NVDA
+$7.63M
4
AMZN icon
Amazon
AMZN
+$5.14M
5
TSLA icon
Tesla
TSLA
+$4.94M

Sector Composition

Rank Sector Weight
1 Technology 37.9%
2 Healthcare 15.37%
3 Consumer Discretionary 12.43%
4 Communication Services 8.94%
5 Energy 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MMM icon
301
3M
MMM
$89B
$1.06M 0.06%
12,705
+523
+4% +$44.4K
OKTA icon
302
Okta
OKTA
$24.1B
$1.06M 0.06%
15,325
+2,914
+23% +$221K
BHP icon
303
BHP
BHP
$213B
$1.06M 0.06%
17,698
-1,490
-8% -$88.9K
SWKS icon
304
Skyworks Solutions
SWKS
$9.06B
$1.06M 0.06%
9,533
+1,627
+21% +$172K
VRDN icon
305
Viridian Therapeutics
VRDN
$2.13B
$1.05M 0.06%
44,170
+11,270
+34% +$289K
CIEN icon
306
Ciena
CIEN
$55.3B
$1.05M 0.06%
24,642
+2,896
+13% +$132K
AMX icon
307
America Movil
AMX
$78.1B
$1.04M 0.06%
48,092
+5,286
+12% +$115K
TER icon
308
Teradyne
TER
$54.8B
$1.04M 0.06%
9,325
+1,542
+20% +$155K
CERE
309
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$1.04M 0.06%
32,605
-6,711
-17% -$206K
ES icon
310
Eversource Energy
ES
$28.2B
$1.03M 0.06%
14,521
-1,296
-8% -$96.5K
VKTX icon
311
Viking Therapeutics
VKTX
$4.04B
$1.02M 0.05%
62,688
-35,528
-36% -$744K
SCHW
312
Charles Schwab
SCHW
$177B
$1.01M 0.05%
17,774
-786
-4% -$41.2K
DOCU
313
DocuSign
DOCU
$9.63B
$1M 0.05%
19,605
+3,312
+20% +$175K
YUM icon
314
Yum! Brands
YUM
$41B
$989K 0.05%
7,140
+2,342
+49% +$318K
HCA icon
315
HCA Healthcare
HCA
$84.8B
$982K 0.05%
3,237
-10
-0.3% -$2.78K
HLT icon
316
Hilton Worldwide
HLT
$74B
$979K 0.05%
6,726
+2,180
+48% +$310K
CHX
317
DELISTED
ChampionX
CHX
$975K 0.05%
31,401
-352
-1% -$9.69K
BLUE
318
DELISTED
bluebird bio
BLUE
$970K 0.05%
14,734
-117
-0.8% -$8.56K
APH icon
319
Amphenol
APH
$188B
$969K 0.05%
22,818
+5,904
+35% +$229K
PPG icon
320
PPG Industries
PPG
$25.9B
$968K 0.05%
6,527
+345
+6% +$48.1K
DHI icon
321
D.R. Horton
DHI
$41B
$960K 0.05%
7,892
+2,558
+48% +$280K
LSCC icon
322
Lattice Semiconductor
LSCC
$17.6B
$960K 0.05%
9,996
+353
+4% +$30.4K
ROP icon
323
Roper Technologies
ROP
$36.3B
$956K 0.05%
1,989
+534
+37% +$242K
CB icon
324
Chubb
CB
$140B
$953K 0.05%
4,950
-100
-2% -$19.6K
EQT icon
325
EQT Corp
EQT
$33.2B
$949K 0.05%
23,065
-2,811
-11% -$99.4K

Similar funds

Profund Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Profund Advisors held 1,158 positions worth $1.86B, up 15% from $1.62B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Profund Advisors deployed $82.5M of net new capital in Q2 2023, opening 69 new positions and adding to 498 existing holdings. Its largest new stake was Biomea Fusion: 24,713 shares worth $542K.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Fiserv Inc, an estimated $3.11M trimmed.

  • Profund Advisors's largest Q2 2023 buy was Biomea Fusion: 24,713 shares worth $542K.
  • Profund Advisors added most to Apple in Q2 2023, an estimated $12.9M increase.
  • Profund Advisors's biggest Q2 2023 reduction was Fiserv Inc, cutting an estimated $3.11M.
  • Profund Advisors fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $1.23M.
  • Profund Advisors's ten largest holdings make up 34% of its $1.86B portfolio in Q2 2023.
  • Profund Advisors opened 69 new positions and closed 91 in Q2 2023.
  • Profund Advisors's portfolio value rose 15% quarter-over-quarter to $1.86B.

Based on Profund Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.